1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Patología Molecular del Cáncer

Patología Molecular del Cáncer

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Melchor L, Molyneux G, Mackay A, Magnay FA, Atienza M, Kendrick H, Nava-Rodrigues D, López-García MÁ, Milanezi F, Greenow K, Robertson D, Palacios J, Reis-Filho JS, Smalley MJ.

    Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models

    JOURNAL OF PATHOLOGY . 233(2): 124-137. Nº de citas: 33

    [doi:10.1002/path.4345]

  • Molina-Pinelo S, Gutiérrez G, Pastor MD, Hergueta M, Moreno-Bueno G, García-Carbonero R, Nogal A, Suárez R, Salinas A, Pozo-Rodríguez F, Lopez-Rios F, Agulló-Ortuño MT, Ferrer I, Perpiñá A, Palacios J, Carnero A, Paz-Ares L.

    MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer

    Plos One . 9(3): . Nº de citas: 57

    [doi:10.1371/journal.pone.0090524]

  • Gutierrez-Pecharroman A, Tirado-Zambrana P, Pascual A, Rubio-Marin D, García-Cosío M, Moratalla-Bartolomé E, Palacios J.

    A Uterine Tumor Resembling Ovarian Sex Cord Tumor Associated With Tamoxifen Treatment: A Case Report and Literature Review

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY . 33(2): 151-155. Nº de citas: 3

    [doi:10.1097/PGP.0b013e318286b4d9]

  • Díaz-Martín J, Díaz-López A, Moreno-Bueno G, Castilla MÁ, Rosa-Rosa JM, Cano A, Palacios J.

    A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition

    JOURNAL OF PATHOLOGY . 232(3): 319-329. Nº de citas: 57

    [doi:10.1002/path.4289]

  • Romero-Pérez L, López-García MÁ, Díaz-Martín J, Biscuola M, Castilla MÁ, Tafe LJ, Garg K, Oliva E, Matias-Guiu X, Soslow RA, Palacios J.

    ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma

    MODERN PATHOLOGY . 26(11): 1514-1524. Nº de citas: 55

    [doi:10.1038/modpathol.2013.93]

  • Leandro-García LJ, Inglada-Pérez L, Pita G, Hjerpe E, Leskelä S, Jara C, Mielgo X, González-Neira A, Robledo M, Avall-Lundqvist E, Gréen H, Rodríguez-Antona C.

    Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy

    JOURNAL OF MEDICAL GENETICS . 50(9): 599-605. Nº de citas: 57

    [doi:10.1136/jmedgenet-2012-101466]

  • Leskela S, Rodríguez-Muñoz A, de la Fuente H, Figueroa-Vega N, Bonay P, Martín P, Serrano A, Sánchez-Madrid F, González-Amaro R, Marazuela M.

    Plasmacytoid Dendritic Cells in Patients With Autoimmune Thyroid Disease

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 98(7): 2822-2833. Nº de citas: 19

    [doi:10.1210/jc.2013-1273]

  • Dabbs DJ, Schnitt SJ, Geyer FC, Weigelt B, Baehner FL, Decker T, Eusebi V, Fox SB, Ichihara S, Lakhani SR, Palacios J, Rakha E, Richardson AL, Schmitt FC, Tan PH, Tse GM, Vincent-Salomon A, Ellis IO, Badve S, Reis-Filho JS.

    Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY . 37(7): 1-11. Nº de citas: 84

    [doi:10.1097/PAS.0b013e3182918a2b]

  • González Martín A, Redondo A, Jurado M, De Juan A, Romero I, Bover I, Del Campo JM, Cervantes A, García Y, López-Guerrero JA, Mendiola C, Palacios J, Rubio MJ, Poveda Velasco A.

    GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012

    CLINICAL & TRANSLATIONAL ONCOLOGY . 15(7): 509-525. Nº de citas: 9

    [doi:10.1007/s12094-012-0995-8]

  • Ballester-Martínez MA, González-García C, Fleta-Asín B, Burdaspal-Moratilla A, Santón-Roldán A, Jiménez-Gómez N, Martín-González MM, Olasolo PJ.

    Cutaneous Nodules as a Diagnostic Clue in Multiple Myeloma

    AMERICAN JOURNAL OF DERMATOPATHOLOGY . 35(3): 377-380. Nº de citas: 11

    [doi:10.1097/DAD.0b013e3182726e79]

  • Biscuola M, Van de Vijver K, Castilla MÁ, Romero-Pérez L, López-García MÁ, Díaz-Martín J, Matias-Guiu X, Oliva E, Palacios Calvo J.

    Oncogene alterations in endometrial carcinosarcomas

    HUMAN PATHOLOGY . 44(5): 852-859. Nº de citas: 16

    [doi:10.1016/j.humpath.2012.07.027]

  • Díaz-García CV, Agudo-López A, Pérez C, López-Martín JA, Rodríguez-Peralto JL, de Castro J, Cortijo A, Martínez-Villanueva M, Iglesias L, García-Carbonero R, Fresno Vara JA, Gámez-Pozo A, Palacios J, Cortés-Funes H, Paz-Ares L, Agulló-Ortuño MT.

    DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification

    Carcinogenesis . 34(5): 1031-1038. Nº de citas: 35

    [doi:10.1093/carcin/bgt022]

  • Kamieniak MM, Muñoz-Repeto I, Rico D, Osorio A, Urioste M, García-Donas J, Hernando S, Robles-Díaz L, Ramón Y Cajal T, Cazorla A, Sáez R, García-Bueno JM, Domingo S, Borrego S, Palacios J, van de Wiel MA, Ylstra B, Benítez J, García MJ.

    DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas

    BRITISH JOURNAL OF CANCER . 108(8): 1732-1742. Nº de citas: 12

    [doi:10.1038/bjc.2013.141]

  • García MJ, Saucedo-Cuevas LP, Muñoz-Repeto I, Fernández V, Robles MJ, Domingo S, Palacios J, Aracil M, Nieto A, Tercero JC, Benítez J.

    Analysis of DNA Repair-Related Genes in Breast Cancer Reveals CUL4A Ubiquitin Ligase as a Novel Biomarker of Trabectedin Response

    MOLECULAR CANCER THERAPEUTICS . 12(4): 530-541. Nº de citas: 16

    [doi:10.1158/1535-7163.MCT-12-0768]

  • Romero-Pérez L, Castilla MÁ, López-García MÁ, Díaz-Martín J, Biscuola M, Ramiro-Fuentes S, Oliva E, Matias-Guiu X, Prat J, Cano A, Moreno-Bueno G, Palacios J.

    Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis

    HUMAN PATHOLOGY . 44(2): 244-254. Nº de citas: 26

    [doi:10.1016/j.humpath.2012.05.013]

  • Yeramian A, Moreno-Bueno G, Dolcet X, Catasus L, Abal M, Colas E, Reventos J, Palacios J, Prat J, Matias-Guiu X.

    Endometrial carcinoma: molecular alterations involved in tumor development and progression

    Oncogene . 32(4): 403-413. Nº de citas: 120

    [doi:10.1038/onc.2012.76]

  • Muñoz-Repeto I, García MJ, Kamieniak M, Ramón Y Cajal T, Domingo S, Cazorla A, García Donas J, Hernando Polo S, García Sagredo JM, Hernández E, Lacambra C, Saez R, Robles L, Borrego S, Prat J, Palacios J, Benítez J.

    Phenotypic characterization of hereditary epithelial ovarian cancer based on a tissue microarray study

    HISTOLOGY AND HISTOPATHOLOGY . 28(1): 133-144. Nº de citas: 3

  • Castilla MÁ, Díaz-Martín J, Sarrió D, Romero-Pérez L, López-García MÁ, Vieites B, Biscuola M, Ramiro-Fuentes S, Isacke CM, Palacios J.

    MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes

    Plos One . 7(10): . Nº de citas: 84

    [doi:10.1371/journal.pone.0047709]